shares of cardiol therapeutics inc are trading higher monday after the company said it expanded its phase iiiii lancer trial to hospital centers in brazil mexico and canada the trial is looking at the efficacy and safety of cardiols cardiolrx in preventing cardiovascular complications in hospital patients with covid19 and suffering or at risk for cardiovascular disease the company said the trial is currently enrolling patients at hospital centers in the us cardiol said at 1139 am et the companys shares were trading 1501 higher on the nasdaq at 452 each volume at the time topped 592000 shares above the stocks 65day average volume of 529369 at 1128 am et the stock was trading 1155 higher on the toronto stock exchange at c541